Pediatrix Medical Group (NYSE:MD) Sets New 52-Week High – Should You Buy?

Pediatrix Medical Group, Inc. (NYSE:MD)’s stock price hit a new 52-week high on Friday. The company traded as high as $28.02 and last traded at $27.8280, with a volume of 17,562 shares traded. The stock had previously closed at $27.76.

Wall Street Analyst Weigh In

MD has been the subject of several recent research reports. Wall Street Zen upgraded shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 13th. UBS Group boosted their price target on Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Jefferies Financial Group downgraded shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and increased their price objective for the company from $27.00 to $28.00 in a report on Wednesday, August 19th. Truist Financial raised their target price on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $25.00 price objective on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and a consensus price target of $26.60.

Pediatrix Medical Group Stock Performance

The company has a market cap of $2.23 billion, a P/E ratio of 13.17 and a beta of 0.61. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.32 and a quick ratio of 1.32. The business has a 50-day moving average of $26.45 and a two-hundred day moving average of $24.68.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.59 by $0.04. The company had revenue of $487.78 million for the quarter, compared to analyst estimates of $478.49 million. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.53 EPS. On average, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 2.17 EPS for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Institutional investors have recently modified their holdings of the business. BlackRock Inc. acquired a new position in Pediatrix Medical Group during the second quarter worth $347,383,000. Wasatch Advisors LP purchased a new position in Pediatrix Medical Group in the 1st quarter worth approximately $43,861,000. Bank of New York Mellon Corp acquired a new position in Pediatrix Medical Group during the second quarter worth $14,297,000. Rockefeller Capital Management L.P. grew its holdings in shares of Pediatrix Medical Group by 814.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 594,351 shares of the company’s stock valued at $12,713,000 after purchasing an additional 529,367 shares during the period. Finally, Empowered Funds LLC purchased a new stake in shares of Pediatrix Medical Group in the 2nd quarter valued at approximately $12,668,000. 97.71% of the stock is currently owned by institutional investors and hedge funds.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc provides physician-led health care services to hospitals, health systems and patients across the United States. The company focuses on specialized care for women, infants and children, supporting patients in hospital-based and affiliated clinical settings.

Its services include neonatal and perinatal care, maternal-fetal medicine, pediatric cardiology and other pediatric subspecialties. Pediatrix physicians commonly practice in neonatal intensive care units, delivery rooms, pediatric emergency departments and other hospital departments, working with care teams to manage complex medical needs.

The company was founded in 1979 and operated for many years under the name MEDNAX, Inc It adopted the Pediatrix Medical Group name in 2023 as part of a broader effort to emphasize its pediatric, neonatal and maternal-fetal health care businesses.